A nurse is administering pancrelipase to a child who has cystic fibrosis. Which of the following outcomes should the nurse expect as a therapeutic effect of the treatment?

A. Improved respiratory function: Pancrelipase is a digestive enzyme replacement and does not directly improve lung function. Respiratory management in cystic fibrosis requires separate interventions such as airway clearance and inhaled medications. B. Improved absorption of vitamins B and C: Pancrelipase primarily aids in the digestion of fats, proteins, and carbohydrates. While it improves absorption of fat-soluble vitamins (A, D, E, K), it does not specifically enhance absorption of water-soluble vitamins like B and C. C. Decreased sodium excretion: Pancrelipase does not influence electrolyte excretion, including sodium. Electrolyte management in cystic fibrosis requires separate monitoring and supplementation as needed. D. Reduced fat in the stools: The therapeutic effect of pancrelipase is to aid digestion of fats, reducing steatorrhea (fatty stools). Successful treatment improves nutrient absorption and decreases gastrointestinal symptoms related to fat malabsorption.